ESX secretion systems: mycobacterial evolution to counter host immunity MI Gröschel, F Sayes, R Simeone, L Majlessi, R Brosch Nature Reviews Microbiology 14 (11), 677-691, 2016 | 356 | 2016 |
Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo R Simeone, F Sayes, O Song, MI Gröschel, P Brodin, R Brosch, L Majlessi PLoS pathogens 11 (2), e1004650, 2015 | 224 | 2015 |
Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection MI Gröschel, F Sayes, SJ Shin, W Frigui, A Pawlik, M Orgeur, R Canetti, ... Cell reports 18 (11), 2752-2765, 2017 | 111 | 2017 |
The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia MI Gröschel, CJ Meehan, I Barilar, M Diricks, A Gonzaga, M Steglich, ... Nature communications 11 (1), 2044, 2020 | 93 | 2020 |
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines SA Prabowo, MI Gröschel, EDL Schmidt, A Skrahina, T Mihaescu, ... Medical microbiology and immunology 202, 95-104, 2013 | 91 | 2013 |
Therapeutic vaccines for tuberculosis—a systematic review MI Gröschel, SA Prabowo, PJ Cardona, JL Stanford, TS Van der Werf Vaccine 32 (26), 3162-3168, 2014 | 86 | 2014 |
Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: a systematic review VM Kroesen, MI Gröschel, N Martinson, A Zumla, M Maeurer, ... Frontiers in immunology 8, 772, 2017 | 76 | 2017 |
CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection F Sayes, A Pawlik, W Frigui, MI Gröschel, S Crommelynck, C Fayolle, ... PLoS pathogens 12 (7), e1005770, 2016 | 65 | 2016 |
Pathogen-based precision medicine for drug-resistant tuberculosis MI Gröschel, TM Walker, TS van der Werf, C Lange, S Niemann, M Merker PLoS pathogens 14 (10), e1007297, 2018 | 58 | 2018 |
Type VII secretion systems in Gram-positive bacteria D Bottai, MI Gröschel, R Brosch Protein and sugar export and assembly in Gram-positive bacteria, 235-265, 2017 | 57 | 2017 |
Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis C Lange, WA Alghamdi, MH Al‐Shaer, S Brighenti, AH Diacon, ... Journal of internal medicine 284 (2), 163-188, 2018 | 47 | 2018 |
Multiplexed quantitation of intraphagocyte Mycobacterium tuberculosis secreted protein effectors F Sayes, C Blanc, LS Ates, N Deboosere, M Orgeur, F Le Chevalier, ... Cell Reports 23 (4), 1072-1084, 2018 | 39 | 2018 |
GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning MI Gröschel, M Owens, L Freschi, R Vargas, MG Marin, J Phelan, Z Iqbal, ... Genome medicine 13, 1-14, 2021 | 32 | 2021 |
Prioritising children and adolescents in the tuberculosis response of the WHO European Region MI Gröschel, M van den Boom, GB Migliori, M Dara European Respiratory Review 28 (151), 2019 | 28 | 2019 |
A convolutional neural network highlights mutations relevant to antimicrobial resistance in Mycobacterium tuberculosis AG Green, CH Yoon, ML Chen, Y Ektefaie, M Fina, L Freschi, MI Gröschel, ... Nature communications 13 (1), 3817, 2022 | 26 | 2022 |
A diagnostic algorithm to investigate pyrazinamide and ethambutol resistance in rifampin-resistant Mycobacterium tuberculosis isolates in a low-incidence setting S Andres, MI Gröschel, D Hillemann, M Merker, S Niemann, K Kranzer Antimicrobial Agents and Chemotherapy 63 (2), 10.1128/aac. 01798-18, 2019 | 25 | 2019 |
Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection R van Altena, S Duggirala, M IP Groschel, T S van der Werf Current pharmaceutical design 17 (27), 2853-2862, 2011 | 22 | 2011 |
Detection of low-frequency resistance-mediating SNPs in next-generation sequencing data of Mycobacterium tuberculosis complex strains with binoSNP V Dreyer, C Utpatel, TA Kohl, I Barilar, MI Gröschel, S Feuerriegel, ... Scientific Reports 10 (1), 7874, 2020 | 18 | 2020 |
The phylogenetic landscape and nosocomial spread of the multidrugresistant opportunist Stenotrophomonas maltophilia. Nat Commun 11: 2044 MI Gröschel, CJ Meehan, I Barilar, M Diricks, A Gonzaga, M Steglich, ... | 18 | 2020 |
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement J Domínguez, MJ Boeree, E Cambau, D Chesov, F Conradie, V Cox, ... The Lancet Infectious Diseases 23 (4), e122-e137, 2023 | 17 | 2023 |